Drugs / HIV DNA Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01140139 | Sep 2006 → Oct 2009 | — | Swedish Institute for Infectious Disease Control | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03606213 Comparator | Aug 2018 → May 2021 | HIV infectious disease | Steven Deeks | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV DNA Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01140139 ↗ |
| Known as | INO-6145 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03606213 ↗ |
| Modality | Vaccine | “therapeutic HIV-1 DNA vaccine” NCT01140139 ↗ |
| Route | Topical | “was applied topically” NCT01140139 ↗ |